Cargando…
Aurora kinase A, a synthetic lethal target for precision cancer medicine
Recent advances in high-throughput sequencing technologies and data science have facilitated the development of precision medicine to treat cancer patients. Synthetic lethality is one of the core methodologies employed in precision cancer medicine. Synthetic lethality describes the phenomenon of the...
Autores principales: | Mou, Pui Kei, Yang, Eun Ju, Shi, Changxiang, Ren, Guowen, Tao, Shishi, Shim, Joong Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178373/ https://www.ncbi.nlm.nih.gov/pubmed/34050264 http://dx.doi.org/10.1038/s12276-021-00635-6 |
Ejemplares similares
-
Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics
por: Lyu, Junfang, et al.
Publicado: (2020) -
MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism
por: Ren, Guowen, et al.
Publicado: (2023) -
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
por: Liu, Yifan, et al.
Publicado: (2020) -
ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones
por: Tao, Shishi, et al.
Publicado: (2023) -
An analog-sensitive allele of Aurora kinase B is lethal in mouse
por: Vazquez, Berta N., et al.
Publicado: (2021)